Related Experiment Video
Updated: May 29, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Adalimumab-associated pulmonary cryptococcosis
Takashi Iwata1, Teruaki Nagano, Masuhiro Tomita
1Department of Thoracic Surgery, Osaka City University Graduate School of Medicine, Osaka, Osaka, Japan. taiwata@kanrou.net
This case report details the first instance of pulmonary cryptococcosis linked to adalimumab treatment in a rheumatoid arthritis patient. The fungal infection developed despite normal initial tests and persisted after adalimumab withdrawal.
Area of Science:
- Medical Mycology
- Rheumatology
- Pulmonology
Background:
- Adalimumab is a TNF-alpha inhibitor used for rheumatoid arthritis.
- Immunosuppression increases the risk of opportunistic infections.
- Pulmonary infections are a known complication of immunosuppressive therapy.
Observation:
- A 56-year-old female with rheumatoid arthritis developed a pulmonary nodule.
- The patient was on adalimumab, methotrexate, and isoniazid.
- Initial chest imaging and lab tests were unremarkable for infection.
Findings:
- Surgical resection revealed Cryptococcus neoformans fungal infection.
- The pulmonary lesion grew despite adalimumab discontinuation.
- Diagnosis was confirmed via Grocott staining and fungal culture.
Implications:
- Adalimumab may be associated with an increased risk of pulmonary cryptococcosis.
- Early diagnosis and treatment are crucial for managing invasive fungal infections.
- This case highlights the importance of considering fungal infections in patients on immunosuppressants with pulmonary symptoms.
Related Concept Videos
Cryptococcal Meningitis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations